Holen Sie sich die Stockscreener-App
16.04
2.55%
-0.42
Vorhandelsmarkt:
15.95
-0.09
-0.56%
Schlusskurs vom Vortag:
$16.46
Offen:
$16.43
24-Stunden-Volumen:
1.20M
Relative Volume:
1.23
Marktkapitalisierung:
$1.25B
Einnahmen:
$1.64B
Nettoeinkommen (Verlust:
$-495.80M
KGV:
-2.5047
EPS:
-6.404
Netto-Cashflow:
$-45.25M
1W Leistung:
+6.23%
1M Leistung:
+59.13%
6M Leistung:
+22.26%
1J Leistung:
+26.50%
1-Tages-Spanne:
$16.03
$16.70
1-Wochen-Bereich:
$14.74
$16.70
52-Wochen-Spanne:
$8.70
$16.70
Integra Lifesciences Holdings Corp Stock (IART) Company Profile
Firmenname
Integra Lifesciences Holdings Corp
Sektor
Branche
Telefon
(609) 275-0500
Adresse
1100 CAMPUS ROAD, PRINCETON, NJ
Compare IART vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IART
Integra Lifesciences Holdings Corp
|
16.04 | 1.28B | 1.64B | -495.80M | -45.25M | -6.404 |
ABT
Abbott Laboratories
|
85.60 | 150.32B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
305.09 | 117.93B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
73.81 | 97.02B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
48.31 | 72.99B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.47 | 49.50B | 6.30B | 1.07B | 1.09B | 1.8406 |
Integra Lifesciences Holdings Corp Stock (IART) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-15 | Herabstufung | Argus | Buy → Hold |
| 2025-03-31 | Hochstufung | Argus | Hold → Buy |
| 2024-12-02 | Eingeleitet | Morgan Stanley | Underweight |
| 2024-10-07 | Hochstufung | BTIG Research | Sell → Neutral |
| 2024-07-30 | Herabstufung | BTIG Research | Neutral → Sell |
| 2024-07-30 | Herabstufung | Citigroup | Neutral → Sell |
| 2024-05-07 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2024-05-07 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-04-03 | Hochstufung | Citigroup | Sell → Neutral |
| 2023-12-05 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-11-14 | Eingeleitet | CL King | Buy |
| 2023-08-24 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2023-07-12 | Hochstufung | Jefferies | Hold → Buy |
| 2023-06-08 | Herabstufung | Argus | Buy → Hold |
| 2023-05-24 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2023-05-23 | Herabstufung | Citigroup | Neutral → Sell |
| 2022-10-12 | Eingeleitet | Jefferies | Hold |
| 2022-07-25 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-04-13 | Herabstufung | Truist | Buy → Hold |
| 2021-12-17 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2021-09-15 | Herabstufung | BTIG Research | Buy → Neutral |
| 2020-10-08 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2020-05-27 | Eingeleitet | Citigroup | Neutral |
| 2020-04-03 | Eingeleitet | SunTrust | Buy |
| 2020-01-07 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2020-01-07 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2019-01-03 | Eingeleitet | SunTrust | Buy |
| 2018-11-28 | Eingeleitet | UBS | Neutral |
| 2018-08-07 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2018-07-26 | Hochstufung | BTIG Research | Neutral → Buy |
| 2018-07-02 | Herabstufung | Citigroup | Buy → Neutral |
| 2018-01-05 | Fortgesetzt | Cantor Fitzgerald | Neutral |
| 2018-01-02 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2017-11-09 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2017-10-30 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2017-10-27 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2017-06-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2017-05-02 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2017-01-13 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2017-01-06 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2016-12-12 | Eingeleitet | UBS | Buy |
Alle ansehen
Integra Lifesciences Holdings Corp Aktie (IART) Neueste Nachrichten
Integra LifeSciences Hits New 52-Week High at $16.62 - Markets Mojo
Integra LifeSciences Hits Day High with 8.36% Surge in Stock Price - Markets Mojo
Integra LifeSciences Holdings Corporation (IART) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance
Is It Too Late to Buy Integra Lifesciences Holdings Corp (IART) After 8.4% Rally? GF Value Says Undervalued - GuruFocus
IART Upgraded by Citigroup -- Price Target Raised to $16.00 - GuruFocus
Integra LifeSciences stock hits 52-week high at $16.49 - Investing.com
Zacks.com featured highlights include DaVita, Integra LifeSciences, Braskem and LyondellBasell - Yahoo Finance
Regenerative Medicine's Newest Public Company Is Building Tissue, Not Replacing It - Benzinga
A Look At Integra LifeSciences Holdings (IART) Valuation After Recent Share Price Momentum - Yahoo Finance
Why Integra LifeSciences (IART) is a Top Momentum Stock for the Long-Term - Yahoo Finance
A Look At Integra LifeSciences (IART) Valuation After Earnings Beat And CEO Stuart Essig’s Return - simplywall.st
Integra LifeSciences Says Transformation Is Working as SurgiMend Relaunch Nears - Yahoo Finance
Paradigm Capital holds 4.01M shares of Integra LifeSciences (IART) - Stock Titan
The Top 5 Analyst Questions From Integra LifeSciences’s Q1 Earnings Call - Yahoo Finance
Integra LifeSciences (IART) Is Up 6.4% After Essig Returns As CEO With Reaffirmed 2026 Guidance - Yahoo Finance
Integra (IART) director receives 24,338-share stock awards - Stock Titan
Integra (IART) director gets 17,700 RSUs; 882 shares withheld for taxes - Stock Titan
Integra LifeSciences (IART) director receives 17,700 RSU grant - Stock Titan
Integra LifeSciences (IART) director Jeffrey Graves receives 17,700 RSU award - Stock Titan
Renee Wonlai Lo awarded 17,700 RSUs at Integra LifeSciences (IART) - Stock Titan
Integra LifeSciences (IART) director awarded 17,700 deferred RSUs - Stock Titan
Earnings call transcript: Integra LifeSciences beats Q1 2026 expectations - Investing.com
Integra LifeSciences Leadership Shift And ESOP Move Highlight Valuation Gap - Yahoo Finance
Integra LifeSciences (NASDAQ: IART) expands equity plan and elects full board - Stock Titan
IART CLASS ACTION ALERT: Hagens Berman Encourages Integra LifeSciences (IART) Investors with Substantial Losses to Contact Firm’s Attorneys, Securities Fraud Lawsuit Pending - ACCESS Newswire
Integra LifeSciences to webcast May 12 BofA conference talk - Stock Titan
Integra LifeSciences to Present at the BofA Securities 2026 Health Care Conference - GlobeNewswire
Integra LifeSciences Holdings Corporation (NASDAQ:IART) Q1 2026 Earnings Call Transcript - Insider Monkey
symbol__ Stock Quote Price and Forecast - CNN
Integra LifeSciences Holdings Corporation Q1 2026 Earnings Call Summary - Yahoo Finance
Integra LifeSciences Holdings Corporation (IART) Releases Q1 2026 Earnings: Revenue Up but EPS Miss - Quiver Quantitative
Revenue and net loss details for Integra LifeSciences (NASDAQ: IART) Q1 2026 - Stock Titan
Integra LifeSciences Q1 Earnings Call Highlights - Yahoo Finance
Rockwell Automation Posts Upbeat Q2 Results, Joins EverQuote, DigitalOcean And Other Big Stocks Moving Hi - Benzinga
Earnings call transcript: Integra LifeSciences Q1 2026 results beat forecasts, stock surges - Investing.com
Integra Lifesciences Holdings Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Q1 2026 Integra Lifesciences Holdings Corp Earnings Call Transcript - GuruFocus
MSN Money - MSN
Integra LifeSciences (IART) Beats Q1 Earnings and Revenue Estimates - Yahoo! Finance Canada
Integra LifeSciences : Q1’2026 Earnings Call - marketscreener.com
Stuart Essig returns as Integra LifeSciences (NASDAQ: IART) CEO - Stock Titan
Integra: Q1 Earnings Snapshot - marketscreener.com
Integra LifeSciences (NASDAQ: IART) boosts 2026 adjusted EPS outlook - Stock Titan
Integra raises 2026 profit outlook; Integra Skin posts double-digit growth - Stock Titan
Integra LifeSciences (NASDAQ:IART) Exceeds Q1 CY2026 Expectations - Yahoo Finance
Integra LifeSciences Announces Leadership Transition - GlobeNewswire
Integra LifeSciences Names Stuart Essig CEO in Leadership Return, Adds New Commercial Chief - citybiz
What To Expect From Integra LifeSciences’s (IART) Q1 Earnings - Yahoo Finance
Integra LifeSciences (IART) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release - Yahoo Finance
Integra LifeSciences (IART) to Release Earnings on Tuesday - MarketBeat
RS Investment Management's Integra Lifesciences Holdings Corp(IART) Holding History - GuruFocus
Finanzdaten der Integra Lifesciences Holdings Corp-Aktie (IART)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.59%
1.94%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):